Le Lézard
Classified in: Covid-19 virus
Subjects: Funding, Bond Issue

Upstream Holdings, Inc. Announces BBB- Investment Grade Rating from Egan-Jones Ratings Company on the Company and Notes Due 2028


Upstream Holdings, Inc. (the "Company") announced that it has received an investment grade rating of "BBB-" from Egan-Jones Ratings Company, an independent, unaffiliated rating agency on the Company and Notes due 2028 (the "Notes").

Egan-Jones is a Nationally Recognized Statistical Rating Organization (NRSRO) and is recognized by the National Association of Insurance Commissioners (NAIC) as a Credit Rating Provider (CRP). Egan-Jones is also certified by the European Securities and Markets Authority (ESMA).

This press release does not constitute an offer to sell or the solicitation of an offer to buy, nor will there be any sale of, the Notes referred to in this press release in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state or jurisdiction.

About Upstream Holdings, Inc.

Upstream Holdings, Inc. is rapidly growing insurance holding company that provides best in class life insurance, annuity and retirement solutions to retirees in the U.S. The Company operates through its wholly owned subsidiaries, Upstream Life Insurance Company ("Upstream Life") and Upstream Insurance Company of Tennessee ("Upstream Re"). Upstream Life is a nationally licensed life insurance company that designs and develops in-demand annuity products that are distributed through independent distribution channels. Upstream Re is a Tennessee licensed insurance company that provides reinsurance and capital for fixed annuity liabilities originated and administered by unaffiliated insurers. The Company also provides operational and regulatory infrastructure and expertise to enable asset managers and third-party investors to form, capitalize and manage their own reinsurance vehicles.

Forward Looking Statements

Statements included herein contain certain "forward-looking statements" which relate to future events or our future performance or financial condition. Forward-looking statements can be identified by the use of forward looking words such as "outlook," "believes," "expects," "potential," "continues," "may," "will," "should," "seeks," "approximately," "predicts," "intends," "plans," "estimates," "anticipates" or negative versions of those words, other comparable words or other statements that do not relate to historical or factual matters. The forward-looking statements are based on our beliefs, assumptions and expectations of our future performance, taking into account all information currently available to us. These statements are not guarantees of future performance, condition or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including but not limited to the impact of the COVID-19 pandemic and the pandemic's impact on the U.S. and global economy, as well as those described from time to time in our filings with the NAIC. Any forward-looking statement speaks only as of the date on which it is made. The Company undertakes no duty to update any forward-looking statements made herein, whether as a result of new information, future developments or otherwise, except as required by law.


These press releases may also interest you

at 15:05
The "Europe In-Vitro Diagnostics (IVD) Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering. Europe's in-vitro diagnostics (IVDs) market is expected to grow at a CAGR of 2.23% from 2023 to 2029. The...

at 14:42
Investor sentiment related to global supply chain risk and channel optimization has recently shifted. Growing geopolitical tensions between the U.S. and China and significant underperformance by high profile eCommerce businesses have caused investors...

at 11:35
Vasomune Therapeutics Inc., a clinical-stage biopharmaceutical company focused on the development of AV-001 for the treatment of diseases associated with vascular dysfunction, today announced that the Company will present a Late-Breaking scientific...

at 11:35
The Honourable Soraya Martinez Ferrada, minister of Tourism and minister responsible for the Economic Development Agency of Canada for the Regions of Quebec, visited Polytechnique Montréal today to announce the cross-Canada results of Stage 2 of the...

at 11:20
Achieve Life Sciences, Inc. , a...

at 11:15
McEwen Mining Inc. invites you to join our conference call following the release of our Q1 2024 financial results on Thursday, May 9th, 2024 at 11:00 AM EDT, where management will discuss our financial results and project developments and follow...



News published on and distributed by: